» Authors » Ziba Veisi Malekshahi

Ziba Veisi Malekshahi

Explore the profile of Ziba Veisi Malekshahi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 233
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Arsanjani A, Faradonbeh D, Malekshahi Z, Mosayyebi B, Negahdari B
Drug Dev Res . 2025 Mar; 86(2):e70072. PMID: 40079269
Tissue plasminogen activators (tPAs) are critical in fibrinolysis and have become central to treating thrombotic disorders, including heart attacks, strokes, and pulmonary embolisms. Despite their efficacy, challenges such as bleeding...
2.
Alipour B, Malekshahi Z, Pourjafar F, Faridi-Majidi R, Negahdari B
Biochem Biophys Res Commun . 2024 Sep; 734:150591. PMID: 39255745
Breast cancer is a prominent cause of death among women and is distinguished by a high occurrence of metastasis. From this perspective, apart from conventional therapies, several alternative approaches have...
3.
Ranjbar F, Ranjbar A, Malekshahi Z, Taghdiri-Nooshabadi Z, Faradonbeh D, Youseflee P, et al.
Cell Tissue Bank . 2023 Dec; 25(1):389-400. PMID: 38159136
Exosomes, the naturally secreted nanocarriers of cells, have recently been demonstrated to have therapeutic benefits in a variety of disease models where parent cells are not present. However, the use...
4.
Danaeifar M, Negahdari B, Mobaleghol Eslam H, Zare H, Ghanaat M, Koushali S, et al.
Biotechnol Lett . 2023 Jun; 45(9):1053-1072. PMID: 37335426
Cancer is one of the leading causes of death and mortality in the world. There is an essential need to develop new drugs or therapeutic approaches to manage treatment-resistant cancers....
5.
Danaeifar M, Malekshahi Z, Kazemi-Lomedasht F, Mazlomi M
Rep Biochem Mol Biol . 2022 Sep; 11(2):252-261. PMID: 36164634
Background: In the field of recombinant protein production, downstream processing, especially protein purification, is critical and often the most expensive step. Carbohydrate binding module 64 (CBM64) was shown in 2011...
6.
Ghanaat M, Kaboosi H, Negahdari B, Fattahi E, Malekshahi Z
Curr Pharm Biotechnol . 2022 Sep; 24(9):1195-1203. PMID: 36154591
Background: Nanocarriers are these days considered an attractive approach in cancer immunotherapy owing to their ability to deliver antigens to antigen-presenting cells (APCs) for stimulating robust immune cells against the...
7.
Mobahat M, Sadroddiny E, Nooshabadi V, Ebrahimi-Barough S, Goodarzi A, Malekshahi Z, et al.
Cell Tissue Bank . 2022 May; 24(1):75-91. PMID: 35641803
Parkinson disease (PD) is considered as one of the most worldwide neurodegenerative disorders. The major reasons associated to neurodegeneration process of PD pathogenesis are oxidative stress. Many studies reported that...
8.
Valipour E, Ranjbar F, Mousavi M, Ai J, Malekshahi Z, Mokhberian N, et al.
Microvasc Res . 2022 May; 143:104385. PMID: 35609635
Exosomes are endogenous nanoparticles with a lipid bilayer membrane whose natural function as carriers of biological materials has attracted much attention. The ability of exosomes to cross biological barriers, especially...
9.
Mohsenikia M, Khalighfard S, Alizadeh A, Khori V, Ghandian Zanjan M, Zare M, et al.
Cell Cycle . 2022 Apr; 21(16):1753-1774. PMID: 35470783
The present study aimed to explore the involved lncRNA-miRNA-mRNA network in the cell cycle and proliferation after conventional treatments in Luminal A breast cancer patients.The candidate miRNAs (miRs), lncRNAs, and...
10.
Gholami L, Khorsandi K, Nooshabadi V, Shahabi S, Jazaeri M, Esfahani H, et al.
Photochem Photobiol . 2022 Apr; 98(6):1447-1458. PMID: 35398890
The current study intended to evaluate the effect of photobiomodulation on the morphology and function of EVs secreted from mesenchymal stem cells (MSCs) derived from periodontal ligament (PDL) and the...